More Evidence Supports Making a Change for Kidney Health
The evidence is in, and it points in one direction. Policymakers need to join the effort to make meaningful change for kidney health.
Lung Advocates are Speaking Up
What can advocates do about a preventable disease with a complex name that affects 391 million people? Raise awareness.
England Prioritizes Personalized Cardiovascular Care
England is taking new steps to prevent life-threatening cardiovascular disease and improve outcomes for patients.
Early Detection Means Better Outcomes for Kidney Patients
Every year an estimated 35 million people die from kidney disease-related complications. Without timely diagnosis and treatment, this number could continue to rise.
Access to Care Shouldn’t be Rare
Everyone deserves equitable access to health care. For the 300 million people across the globe living with a rare disease, however, this is no easy feat.
The Importance of Early Diagnosis and Real-World Evidence to Drive Better Patient Outcomes
Of the 500,000 people across Europe who live with a rare neurological disease, 60% remain undiagnosed.1 A recent roundtable event, Rare Neurological Diseases in the EU, explored how early diagnosis and real-world evidence can help.
Increasing Health Access Through Telemedicine
A new digital health platform could make it easier for people with cancer, diabetes and other non-communicable diseases to access care.
Protecting Medical Innovation Protects Patient Access
Scientific breakthroughs and innovative medicines offer new promise for millions of patients battling life threatening cancers, Alzheimer’s and global pandemics.
Driving Better Patient Outcomes in Rare Neurological Diseases
Across Europe, between 5000 and 8000 people face rare, chronically disabling or life-threatening disorders.
South Africa’s Silent Disease
Your bones matter. That’s the message at the heart of a new campaign aimed at reducing the burden of osteoporosis in South Africa.
